An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.

The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.

Read the full article

References

Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).

Share this

Related Posts

Some Fish Hear with Their Bones and Communicate in an Unusual Way

Tinnitus Severity Linked to Mood, Sleep, and Personality

Influence of the Electrical Dynamic Range (EDR) on Speech Perception, Vocabulary, and Quality of Life in Young Children

Recent Posts

When Audiologists Lead, Patients Win

Level Up Your Practice at AAA 2026—Bring Your Assistant and Take Advantage of Exclusive Package Discounts! The Audiology Assistant Track is back by popular demand at AAA 2026,…

Read More
Utah Committee Removes Audiology Deregulation Language After Strong Professional Pushback

Utah Committee Removes Audiology Deregulation Language After Strong Professional Pushback

Early last week, the Utah Office of Professional Licensing Review (OPLR) released draft legislation proposing major revisions to the regulatory framework for licensure of multiple…

Read More
Academy Joins National Push for Inclusive Loan Rules for Health Professions

Academy Joins National Push for Inclusive Loan Rules for Health Professions

Late last month, the Academy signed onto a letter to the Department of Education and the Reimagining and Improving Student Education (RISE) rulemaking committee urging…

Read More